De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07).
Sabine R de WildLori M van RoozendaalJohannes H W de WiltThijs van DalenJos A van der HageFrederieke H van DuijnhovenJanine M SimonsRobert-Jan SchipperLinda de MunckJustin G L M LuermansLiesbeth J BoersmaSabine C LinnMarc B I LobbesPhilip M P PoortmansVivianne C G Tjan-HeijnenKoen K B T van de VijverJolanda de VriesA Helen WestenbergLuc J A StrobbeMarjolein L SmidtPublished in: The British journal of surgery (2024)
In this registry study of patients with cT1-2 N0 breast cancer treated with mastectomy, with low-volume sentinel lymph node metastasis, the 5-year regional recurrence rate was low and comparable between patients with and without completion axillary treatment.